| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -317,975 | -60,499 |
| Effect of exchange rate changes on cash and cash equivalents | 337 | 204 |
| Net (decrease) increase in cash and cash equivalents | -129,185 | 23,710 |
| Cash and cash equivalents at beginning of period | 276,774 | - |
| Cash and cash equivalents at end of period | 147,589 | - |
Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. (PCRX)